【発明の名称】エリスロポエチン投与の薬物速度論的および薬力学的モデリング - Ortho-McNail Pharmaceuticals Incorporated

Title:

【発明の名称】エリスロポエチン投与の薬物速度論的および薬力学的モデリング

Document Type and Number:

Japanese Patent JP2003523940

Kind Code:

A

Abstract:

The present invention relates to systems and methods for obtaining optimized EPO dosage regimens for a desired pharmacodynamic/pharmacokinetic response. The system includes choosing one or more EPO dosage regimens, then using a PK/PD model to determine the pharmacodynamic/pharmacokinetic profile of one or more EPO dosage regimens, and finally selecting one of the EPO dosage regimens for administration to achieve the desired pharmacodynamic/pharmacodynamic response based on the EPO profile.

More Like This:

JP2020517618	Combination therapy with EHMT2 inhibitors
WO/2015/102928	COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
WO/2010/004060	USE OF CILASTATIN FOR REDUCING NEPHROTOXICITY OF DIFFERENT COMPOUNDS

Inventors:

Chun, Win
Gibson, david
Felkamen, Els
Coat, christine

Application Number:

JP2000616801A

Publication Date:

August 12, 2003

Filing Date:

May 10, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ortho-McNail Pharmaceuticals Incorporated

International Classes:

A61K31/282; A61K31/7072; A61K33/243; A61K38/00; A61K38/18; A61K38/22; A61M37/00; A61P7/00; A61P7/06; A61P7/08; A61P13/12; A61P19/02; A61P29/00; A61P31/18; A61P35/00; A61P43/00; G06F19/00; G06Q10/00; A61K38/12; (IPC1-7): A61K38/00; A61P7/06; G06F19/00

Attorney, Agent or Firm:

Shusaku Yamamoto

Previous Patent: マクロライド系抗感染剤

Next Patent: ＮＯＳ阻害剤のための新規医薬組合せ